Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depressive Disorder, Major | 27 | 2020 | 4818 | 1.450 |
Why?
|
| Students | 12 | 2021 | 1744 | 1.340 |
Why?
|
| Personality Disorders | 11 | 2008 | 729 | 1.140 |
Why?
|
| Fluoxetine | 14 | 2012 | 733 | 1.060 |
Why?
|
| Depression | 16 | 2019 | 8231 | 0.910 |
Why?
|
| Antidepressive Agents, Second-Generation | 9 | 2012 | 491 | 0.870 |
Why?
|
| Universities | 10 | 2019 | 1005 | 0.840 |
Why?
|
| Compulsive Behavior | 3 | 2012 | 117 | 0.800 |
Why?
|
| Citalopram | 2 | 2015 | 401 | 0.730 |
Why?
|
| Psychiatric Status Rating Scales | 17 | 2022 | 6030 | 0.580 |
Why?
|
| Suicidal Ideation | 4 | 2022 | 1462 | 0.570 |
Why?
|
| Anxiety | 6 | 2015 | 4672 | 0.520 |
Why?
|
| Risk-Taking | 2 | 2012 | 1023 | 0.510 |
Why?
|
| Personality Inventory | 9 | 2019 | 1018 | 0.420 |
Why?
|
| Irritable Mood | 1 | 2013 | 196 | 0.400 |
Why?
|
| Anxiety Disorders | 4 | 2012 | 2749 | 0.390 |
Why?
|
| Parkinson Disease | 3 | 2011 | 2895 | 0.390 |
Why?
|
| Depressive Disorder | 9 | 2012 | 3723 | 0.370 |
Why?
|
| Alcohol Drinking | 3 | 2012 | 4045 | 0.350 |
Why?
|
| Delusions | 3 | 2022 | 301 | 0.340 |
Why?
|
| Hostility | 1 | 2010 | 185 | 0.330 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 9 | 2010 | 1988 | 0.330 |
Why?
|
| Cognition Disorders | 3 | 2015 | 3985 | 0.310 |
Why?
|
| Stress, Psychological | 5 | 2013 | 4530 | 0.290 |
Why?
|
| Anger | 1 | 2010 | 405 | 0.290 |
Why?
|
| Fatigue | 1 | 2015 | 1557 | 0.290 |
Why?
|
| Perceptual Distortion | 1 | 2007 | 36 | 0.280 |
Why?
|
| Severity of Illness Index | 13 | 2015 | 15951 | 0.270 |
Why?
|
| Comorbidity | 16 | 2015 | 10592 | 0.250 |
Why?
|
| Antidepressive Agents | 4 | 2012 | 2913 | 0.230 |
Why?
|
| Psychometrics | 6 | 2012 | 3066 | 0.210 |
Why?
|
| Suicide | 3 | 2022 | 1606 | 0.200 |
Why?
|
| Placebo Effect | 1 | 2006 | 518 | 0.200 |
Why?
|
| Somatoform Disorders | 1 | 2005 | 425 | 0.190 |
Why?
|
| Psychotic Disorders | 3 | 2022 | 3278 | 0.190 |
Why?
|
| Attitude | 1 | 2007 | 772 | 0.190 |
Why?
|
| Amygdala | 2 | 2019 | 1379 | 0.190 |
Why?
|
| Social Perception | 1 | 2004 | 433 | 0.180 |
Why?
|
| Young Adult | 22 | 2022 | 60131 | 0.180 |
Why?
|
| Personal Space | 1 | 2021 | 36 | 0.180 |
Why?
|
| Remission Induction | 4 | 2012 | 2408 | 0.170 |
Why?
|
| Treatment Outcome | 17 | 2019 | 65480 | 0.170 |
Why?
|
| Male | 48 | 2019 | 365203 | 0.170 |
Why?
|
| Female | 48 | 2020 | 397515 | 0.150 |
Why?
|
| Hypericum | 2 | 2011 | 58 | 0.150 |
Why?
|
| Phytotherapy | 2 | 2011 | 298 | 0.140 |
Why?
|
| Adolescent | 24 | 2022 | 89244 | 0.140 |
Why?
|
| Emotions | 2 | 2018 | 2768 | 0.130 |
Why?
|
| Adult | 34 | 2020 | 223851 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 4423 | 0.130 |
Why?
|
| Obsessive Behavior | 1 | 2016 | 51 | 0.130 |
Why?
|
| Humans | 58 | 2022 | 768970 | 0.130 |
Why?
|
| Self Report | 4 | 2018 | 3773 | 0.130 |
Why?
|
| Yoga | 1 | 2019 | 280 | 0.120 |
Why?
|
| Cannabis | 1 | 2021 | 446 | 0.120 |
Why?
|
| Psychology, Comparative | 1 | 2013 | 6 | 0.110 |
Why?
|
| Regression Analysis | 4 | 2019 | 6346 | 0.110 |
Why?
|
| Massachusetts | 3 | 2015 | 8894 | 0.110 |
Why?
|
| Sex Factors | 4 | 2012 | 10633 | 0.100 |
Why?
|
| Middle Aged | 28 | 2020 | 223737 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2019 | 1441 | 0.100 |
Why?
|
| Self-Assessment | 2 | 2013 | 400 | 0.100 |
Why?
|
| Health Status | 4 | 2010 | 4095 | 0.100 |
Why?
|
| Demography | 3 | 2013 | 1642 | 0.100 |
Why?
|
| Prevalence | 5 | 2012 | 15879 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2019 | 1112 | 0.090 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2012 | 276 | 0.090 |
Why?
|
| Plant Preparations | 1 | 2011 | 94 | 0.090 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 807 | 0.090 |
Why?
|
| Fear | 1 | 2019 | 1493 | 0.080 |
Why?
|
| Affective Symptoms | 1 | 2012 | 418 | 0.080 |
Why?
|
| Quality of Life | 5 | 2013 | 13510 | 0.080 |
Why?
|
| Testosterone | 1 | 2020 | 2493 | 0.080 |
Why?
|
| Ambulatory Care | 5 | 2008 | 2784 | 0.080 |
Why?
|
| Alcoholism | 1 | 2019 | 1981 | 0.080 |
Why?
|
| Hallucinations | 2 | 2022 | 375 | 0.080 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 26395 | 0.080 |
Why?
|
| Risk Factors | 10 | 2019 | 74976 | 0.080 |
Why?
|
| Cognition | 1 | 2006 | 7081 | 0.080 |
Why?
|
| Lepidium | 1 | 2008 | 8 | 0.080 |
Why?
|
| Age of Onset | 3 | 2011 | 3346 | 0.080 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 243 | 0.070 |
Why?
|
| Double-Blind Method | 6 | 2020 | 12467 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2018 | 2649 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2012 | 683 | 0.070 |
Why?
|
| Bupropion | 1 | 2008 | 303 | 0.070 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 265 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 1508 | 0.070 |
Why?
|
| Aptitude | 1 | 2006 | 43 | 0.060 |
Why?
|
| Educational Measurement | 1 | 2013 | 1260 | 0.060 |
Why?
|
| Aged | 16 | 2020 | 171786 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2009 | 565 | 0.060 |
Why?
|
| Ethics, Clinical | 1 | 2006 | 101 | 0.060 |
Why?
|
| Age Factors | 5 | 2011 | 18435 | 0.060 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 7861 | 0.060 |
Why?
|
| Plant Extracts | 2 | 2008 | 499 | 0.060 |
Why?
|
| Patient Dropouts | 2 | 2008 | 411 | 0.060 |
Why?
|
| Schizophrenia | 2 | 2021 | 6987 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 36854 | 0.060 |
Why?
|
| Exploratory Behavior | 1 | 2005 | 272 | 0.060 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2008 | 365 | 0.060 |
Why?
|
| Executive Function | 1 | 2013 | 1405 | 0.060 |
Why?
|
| Nicotine | 1 | 2008 | 680 | 0.060 |
Why?
|
| Nortriptyline | 1 | 2003 | 79 | 0.050 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1106 | 0.050 |
Why?
|
| Problem Solving | 1 | 2006 | 443 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2008 | 708 | 0.050 |
Why?
|
| Culture | 1 | 2007 | 623 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2005 | 1002 | 0.050 |
Why?
|
| Motor Activity | 1 | 2013 | 2713 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2007 | 631 | 0.050 |
Why?
|
| Patient Compliance | 2 | 2002 | 2701 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 2666 | 0.050 |
Why?
|
| Eating | 1 | 2008 | 1542 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1204 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4251 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2003 | 430 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2019 | 8748 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2005 | 2280 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 8559 | 0.040 |
Why?
|
| Individuality | 1 | 2021 | 307 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 10400 | 0.040 |
Why?
|
| Mass Screening | 2 | 2012 | 5457 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2002 | 2732 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10765 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18068 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2009 | 2763 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14752 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2008 | 2085 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 20245 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2002 | 8055 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14794 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2022 | 1426 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15471 | 0.030 |
Why?
|
| Perception | 1 | 2021 | 1209 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2020 | 1135 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2022 | 41808 | 0.030 |
Why?
|
| Forecasting | 1 | 2002 | 2945 | 0.030 |
Why?
|
| Life Change Events | 2 | 2008 | 961 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2862 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 40261 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2020 | 1841 | 0.020 |
Why?
|
| Exercise | 1 | 2008 | 5954 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2022 | 2237 | 0.020 |
Why?
|
| Sickness Impact Profile | 1 | 2012 | 299 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 24333 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6320 | 0.020 |
Why?
|
| Sertraline | 1 | 2011 | 209 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2012 | 529 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 13021 | 0.020 |
Why?
|
| Homocysteine | 1 | 2012 | 637 | 0.020 |
Why?
|
| Marriage | 1 | 2010 | 351 | 0.020 |
Why?
|
| Plant Roots | 1 | 2008 | 122 | 0.020 |
Why?
|
| Libido | 1 | 2008 | 124 | 0.020 |
Why?
|
| Health Surveys | 2 | 2008 | 4055 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2022 | 6739 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 716 | 0.020 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2008 | 193 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2010 | 645 | 0.020 |
Why?
|
| Folic Acid | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Placebos | 1 | 2009 | 1667 | 0.020 |
Why?
|
| Aggression | 1 | 2008 | 750 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 21547 | 0.010 |
Why?
|
| Employment | 1 | 2010 | 1114 | 0.010 |
Why?
|
| Social Adjustment | 1 | 2006 | 636 | 0.010 |
Why?
|
| Social Behavior | 1 | 2010 | 1146 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2007 | 826 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2013 | 1960 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1603 | 0.010 |
Why?
|
| Minority Groups | 1 | 2010 | 1216 | 0.010 |
Why?
|
| Educational Status | 1 | 2010 | 2515 | 0.010 |
Why?
|
| Social Isolation | 1 | 2002 | 366 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2006 | 1839 | 0.010 |
Why?
|
| Lipids | 1 | 2009 | 3345 | 0.010 |
Why?
|
| Mental Health | 1 | 2012 | 3275 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2003 | 1599 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2010 | 2518 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7245 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13318 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8513 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3438 | 0.010 |
Why?
|
| Probability | 1 | 2000 | 2483 | 0.010 |
Why?
|
| Brain | 1 | 2021 | 27453 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4862 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9094 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2006 | 54962 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2000 | 10115 | 0.000 |
Why?
|
| Research Design | 1 | 2002 | 6214 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12562 | 0.000 |
Why?
|
| Prognosis | 1 | 2003 | 30046 | 0.000 |
Why?
|
| United States | 1 | 2008 | 73186 | 0.000 |
Why?
|
Concepts
(191)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_